TITLE

REDUCING PNEUMOCOCCAL DISEASE BURDEN

AUTHOR(S)
File Jr., Thomas M.
PUB. DATE
March 2014
SOURCE
Today's Geriatric Medicine;Mar/Apr2014, Vol. 7 Issue 2, p34
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses how the burden of pneumococcal disease, with clinical manifestations of pneumonia and invasive pneumococcal disease (IPD), including meningitis and bacteremia, can be reduced, particularly in older age groups as IPD remains a leading cause of death in the U.S., as of April 2014. The author states that prevention through vaccination, is the best approach for reduction of pneumococcal disease burden, as it lessens infection severity and limits complications.
ACCESSION #
95439911

 

Related Articles

  • Successful pneumococcal vaccination. Silver, Lisa // GP: General Practitioner;10/20/2003, p43 

    Pneumococcal disease, which includes pneumonia, bacteraemia and meningitis, is a serious disease. It is an important cause of morbidity and mortality, particularly among the elderly, the young, those with an absent or non-functioning spleen and those with impaired immunity. For the first time...

  • Resurgence of Serotype 19F Carriage in Preschool Children in Portugal in the Context of Continuing Moderate Conjugate Pneumococcal Vaccine Uptake. Rodrigues, Fernanda; Morales-Aza, Begonia; Holland, Rachel; Gould, Katherine; Hinds, Jason; Gonçalves, Guilherme; Januário, Luís; Finn, Adam // Clinical Infectious Diseases;Aug2013, Vol. 57 Issue 3, p473 

    The article focuses on the resurgence of serotype 19F carriage in preschool children in Portugal. It reports about the reduction to the extinction of pneumococcal, Streptococcus pneumoniae colonization on the use of pneumococcal conjugate vaccine (PCV). It discusses the reduced effectiveness of...

  • Pfizer game-changing vaccine propels company, heals aging patients. Díaz, Mario Belaval // Caribbean Business;3/1/2012, Vol. 40 Issue 8, p38 

    The article focuses on the approval of the U.S. Food and Drug Administration (FDA) on the use of Prevnar 13 vaccine developed by Pfizer Inc. for adult over 50 years old to prevent pneumonia. It says that the vaccine prevent pneumococcal diseases (PD) such as pneumonia in adults. It states that...

  • Pneumococcal vaccination in adults: New perspectives for old problems. Kioumis, Ioannis P. // Pneumon;Jul-Sep2012, Vol. 25 Issue 3, p265 

    The author reflects on pneumococcal vaccination in adults to prevent pneumonia. He notes that the pneumococcal vaccine contains purified pneumococcal capsular antigens from 23 types of pneumococcal bacteria that cause 88% of bacterimic pneumococcal disease. The author also noted the controversy...

  • Do your part to stave off STREP. Schweon, Steven J.; Metulis, Terri J. // RN;Oct2005, Vol. 68 Issue 10, p34 

    Discusses the nursing and medical management of pathogen Streptococcus pneumoniae (S. pneumoniae) and its related disease. Diseases caused by S. pneumoniae; Information on pneumococcal polysaccharide vaccine; Symptoms of pneumonia, bacteremia, and meningitis; Precautions to take when a patient...

  • Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older. Vila-Corcoles, Angel; Ochoa-Gondar, Olga; Guzmán, Jorge A.; Rodriguez-Blanco, Teresa; Salsench, Elisabet; Fuentes, Cruz M. // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p73 

    Background: The 23-valent polysaccharide pneumococcal vaccine (PPV) is currently recommended in elderly and high-risk adults. However, its efficacy in preventing pneumococcal infections remains controversial. This study assessed the clinical effectiveness of vaccination against invasive...

  • Infectious diseases. Segreti, John // Patient Care;1/15/1998, Vol. 32 Issue 1, p105 

    Presents a study entitled `Clinical Efficacy of Pneumococcal Vaccine in the Elderly: A Randomized, Single-Blind Population-Based Trial,' by I. Koivula, M. Sten, M. Leinonen, and others in the 1997 issue of the Am J Med.

  • Pneumococcal jab supplies run short. Dragon, Natalie // GP: General Practitioner;10/21/2002, p1 

    Reports on the shortages of Pneumovax II vaccine used for immunization of old patients against pneumococcal infections in Great Britain. Reasons behind the increase in demand of the vaccines leading to a shortage; Complaints of the general practitioners regarding regular supplies of the...

  • 'Postcode vaccination' fear on pneumococcal jab deal. Kelly, Brian // Pulse;9/23/2002, Vol. 62 Issue 36, p2 

    Reports on the pneumococcal vaccination of the aged in Northern Ireland. Cancellation of the vaccination in Scotland; Impact of the pneumonococcal vaccine on the flu vaccine intake; Postcode vaccination in England.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics